Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Apply
Gemcitabine vs. BCG
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step